Development of a Platform for Systemic Antiangiogenesis Therapy for Advanced Cervical Cancer

Clinical Advances in Hematology & Oncology November 2014, Volume 12, Issue 11 Krishnansu S. Tewari, MD, and Bradley J. Monk, MD Dr Tewari is a gynecologic […]

The Use of Adjuvant Bisphosphonates in the Treatment of Early-Stage Breast Cancer

Clinical Advances in Hematology & Oncology November 2014, Volume 12, Issue 11 Aju Mathew, MD, MPhil, and Adam M. Brufsky, MD, PhD Aju Mathew, MD, MPhil, […]

Platinum Agents in the Treatment of Early-Stage Triple-Negative Breast Cancer: Is It Time to Change Practice?

Clinical Advances in Hematology & Oncology October 2014, Volume 12, Issue 10 Laila Saied Agrawal, MD, and Ingrid A. Mayer, MD, MSCI The authors are […]

Update on the Chemotherapeutic Management of Endometrial Cancer

Clinical Advances in Hematology & Oncology October 2014, Volume 12, Issue 10 Amy Bregar, MD, Katina Robison, MD, and Don S. Dizon, MD Dr Bregar is […]

Practical Recommendations on Incorporating New Oral Anticoagulants Into Routine Practice

Clinical Advances in Hematology & Oncology October 2014, Volume 12, Issue 10 Jaskirat Randhawa, MD, Nirosshan Thiruchelvam, MD, Michael Ghobrial, MD, Timothy Spiro, MD, Bernadette Clark, […]

Hematopoietic Transplant-Associated Thrombotic Microangiopathy: Case Report and Review of Diagnosis and Treatments

Clinical Advances in Hematology & Oncology September 2014, Volume 12, Issue 9 John Chapin, MD, Tsiporah Shore, MD, Peter Forsberg, MD, Garrett Desman, MD, Koen Van […]

Smoldering Multiple Myeloma: Pathophysiologic Insights, Novel Diagnostics, Clinical Risk Models, and Treatment Strategies

Clinical Advances in Hematology & Oncology September 2014, Volume 12, Issue 9 Dickran Kazandjian, MD, Sham Mailankody, MD, Neha Korde, MD, and Ola Landgren, MD, […]

Managing Multifocal Bronchioloalveolar Carcinoma/Lepidic Predominant Adenocarcinoma: Changing Rules for an Evolving Clinical Entity

Clinical Advances in Hematology & Oncology September 2014, Volume 12, Issue 9 Howard (Jack) West, MD Dr West is the medical director of the Thoracic […]

Sequencing Treatment in Chronic Myeloid Leukemia: The First Choice May Be the Hardest

Clinical Advances in Hematology & Oncology August 2014, Volume 12, Issue 8 Mark L. Heaney, MD, PhD Dr Heaney is an associate clinical professor of medicine […]

Yttrium 90-Ibritumomab Tiuxetan Plus Rituximab Maintenance as Initial Therapy for Patients With High-Tumor-Burden Follicular Lymphoma: A Wisconsin Oncology Network Study

Clinical Advances in Hematology & Oncology August 2014, Volume 12, Issue 8 Saurabh Rajguru, MD, Thorhildur Kristinsdottir, MD, Jens Eickhoff, PhD, Chris Peterson, MD, Christine M. […]

ALK Inhibitors in Non–Small Cell Lung Cancer: Crizotinib and Beyond

July 2014, Volume 12, Issue 7 Mark M. Awad, MD, PhD, and Alice T. Shaw, MD, PhD Dr Awad is a fellow in hematology/ -oncology at […]

Room for Improvement: Immunizations for Patients With Monoclonal B-Cell Lymphocytosis or Chronic Lymphocytic Leukemia

July 2014, Volume 12, Issue 7 Jennifer A. Whitaker, MD, MS, Tait D. Shanafelt, MD, Gregory A. Poland, MD, and Neil E. Kay, MD The authors […]

Malignancies Associated With Epstein-Barr Virus: Pathobiology, Clinical Features, and Evolving Treatments

Volume 12, Issue 6 June 2014 Natalia Neparidze, MD, and Jill Lacy, MD Dr Neparidze is an assistant professor of medicine and Dr Lacy is an […]

TNBC vs Non-TNBC: A Retrospective Review of Differences in Mean Age, Family History, Smoking History, and Stage at Diagnosis

Clinical Advances in Hematology & Oncology June 2014, Volume 12, Issue 6 Khurram Tariq, MD, Arezo Farhangi, MD, and Fauzia Rana, MD The authors are affiliated with […]

Update on the Use of Angiogenesis Inhibitors in Adult Patients With Brain Tumors

Clinical Advances in Hematology & Oncology May 2014, Volume 12, Issue 5 David A. Reardon, MD Dr Reardon is the clinical director of the Center for […]

Prescribing for Older Patients With Cancer

Clinical Advances in Hematology & Oncology May 2014, Volume 12, Issue 5 Beatriz Korc-Grodzicki, MD, PhD, Manpreet K. Boparai, PharmD, CGP, and Stuart M. Lichtman, MD […]

Endocrine Therapy for Advanced Breast Cancer

Clinical Advances in Hematology & Oncology April 2014, Volume 12, Issue 4 Payal D. Shah, MD, and Maura N. Dickler, MD Dr Shah is a medical oncology […]

Selective Bcl-2 Inhibition to Treat Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

Clinical Advances in Hematology & Oncology April 2014, Volume 12, Issue 4 Samuel Y. Ng, MD, PhD, and Matthew S. Davids, MD Dr Ng is a clinical […]

The Development of Bevacizumab in Noncolorectal Gastrointestinal Malignancies: Gastroesophageal, Pancreatic, and Hepatocellular Carcinoma

Clinical Advances in Hematology & Oncology April 2014, Volume 12, Issue 4 Manish A. Shah, MD Dr Shah is an associate professor of medicine at Weill Cornell […]

Targeted Therapies for Treatment of Recurrent Ovarian Cancer

Ovarian cancer remains the leading cause of death among women with gynecologic malignancies in the United States. Most women with epithelial ovarian cancer present with advanced disease. Despite good response rates to initial surgery and chemotherapy, the majority of patients experience relapse and ultimately die of their disease. A better understanding of the molecular differences underlying the histologic subtypes of epithelial ovarian cancer has led to recent advances in targeted therapeutic strategies. Here we review the most promising targeted therapeutics currently being used for the treatment of recurrent ovarian cancer.